Hosted on MSN10mon
Eli Lilly's Legal Battle Against Fake Compounded Tirzepatide Products: Bacteria, Impurities DetectedEli Lilly And Co (NYSE:LLY) revealed on Thursday that it has identified bacteria and elevated impurity levels in products falsely claiming to be compounded versions of tirzepatide, the active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback